← Back to Search

Wearable Pedometer for Walking (EARLY Trial)

N/A
Waitlist Available
Led By Jennifer Fishe, MD
Research Sponsored by University of Florida
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 1 month
Awards & highlights

EARLY Trial Summary

This trial will test if a patient wearable device measuring steps and ambulation sessions decreases hospital length of stay, time to first ambulation, time to first bowel movement, incidence of venous thromboembolism, and costs.

Eligible Conditions
  • Walking
  • Wearable Devices

EARLY Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 1 month
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 1 month for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Hospital Length of Stay
Secondary outcome measures
Hospital length-of-stay index
Rate of venous thromboembolism
Time to first ambulation
+2 more

EARLY Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: PedometerExperimental Treatment1 Intervention
Admitted patients who receive a pedometer to wear during their hospital stay to measure steps ambulated
Group II: ControlActive Control1 Intervention
Patients admitted to hospital who do not receive a pedometer, but receive all other usual standard of care
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Wearable Pedometer
2020
N/A
~40

Find a Location

Who is running the clinical trial?

University of FloridaLead Sponsor
1,340 Previous Clinical Trials
715,667 Total Patients Enrolled
Jennifer Fishe, MDPrincipal InvestigatorUniversity of Florida
1 Previous Clinical Trials
1,464 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there still time to join this research endeavor?

"Affirmative. According to the clinicaltrials.gov records, this ongoing medical experiment was initially posted on October 21st 2020 and includes 150 subjects from a single site. The information has been recently updated on March 23rd 2022."

Answered by AI

What is the upper limit of participants in this experiment?

"Affirmative. According to clinicaltrials.gov, the trial was first published on October 21st 2020 and is still actively recruiting participants today. 150 individuals are required for this study at a single site."

Answered by AI

Is this research program open to mature participants above the age of 18?

"This research is seeking participants who are at least 18 years old and no more than a century in age."

Answered by AI

Am I eligible to participate in the experiment?

"This clinical trial seeks 150 individuals capable of ambulating and aged between 18-100. To be eligible, applicants must have physician orders for patient activity upon hospital admission, fall risk scores indicating a low probability of falling, MFS rating < or equal to 50, admitted to UF Health Jacksonville 8N progressive inpatient unit with no skin contraindications at the wrist."

Answered by AI

Who else is applying?

What state do they live in?
Florida
How old are they?
18 - 65
What site did they apply to?
University of Florida
What portion of applicants met pre-screening criteria?
Did not meet criteria
Recent research and studies
clinicaltrials.govStudy
Early Ambulation to Reduce Hospital Length of Stay
2020. "Early Ambulation to Reduce Hospital Length of Stay". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04444453.
~8 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top